Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 1,290,000 shares, an increase of 17.3% from the April 30th total of 1,100,000 shares. Currently, 7.7% of the company’s shares are short sold. Based on an average […]
Opaleye Management Inc. acquired a new position in shares of Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 252,046 shares of the company’s stock, valued at approximately $3,234,000. Aadi Bioscience accounts for approximately […]
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...
Aadi Bioscience (NASDAQ:AADI – Get Rating) had its price target lowered by LADENBURG THALM/SH SH from $47.00 to $33.00 in a research report sent to investors on Thursday morning, The Fly reports. Separately, HC Wainwright reduced their price objective on shares of Aadi Bioscience from $48.00 to $45.00 and set a buy rating for the […]
Operator: Good day and welcome to the Aadi Bioscience First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.